Non-invasive neuromodulation device (Lenire) for tinnitus
| Date | Round | Amount |
|---|---|---|
| Apr 2023 | Debt Alongside its Series B, Neuromod raised 15m EUR in venture debt from the European Investment Bank. | $16.2M |
| Apr 2023 | Series B Dublin medical-device company Neuromod raised a 15m EUR Series B expansion led by Panakes Partners with Fountain Healthcare to roll out its Lenire tinnitus treatment. | $16.2M |